LEV evidence tracker · October 2026
The first human partial-reprogramming trial has started. See what changed, what remains preclinical and what the next evidence threshold requires.
Explore the visual story → Three thresholds. One disciplined question.- NowA human safety trial has begunLocalized optic-nerve therapy
- NextDoes function improve and last?No efficacy result yet
- LEVCan gains outpace aging?Not demonstrated
A current evidence map, not a forecast of when LEV will occur.

Everyday health
The 2025 U.S. blood-pressure guideline gives persistent readings in this range more attention. One reading still does not decide treatment.
Read the story →
Everyday health · 2 min
Some familiar over-the-counter medicines deserve a second look after 65. Bring the actual products to a medication review.
Read the story →
Movement · 2 min
An age-adjusted death rate increased 21 percent from 2018 to 2024. The measure describes a trend, not the odds that a fall will be fatal.
Read the story →
Everyday health · 2 min
A Florida outbreak investigation identified 79 cases linked to Cuba. The report offers a concrete reason to review travel-health advice.
Read the story →
Sleep · 2 min
An online insomnia program helped older adults more than sleep information alone, with benefits still apparent a year later.
Read the story →The long view
2026 Longevity Horizon Report
A framework for longevity planning, evidence, biomarkers and financial endurance.
Explore the report ↗Start here
Biomarker Essentials
A focused starting framework for understanding and tracking biological measurements.
Explore the report ↗Go deeper
Biomarker Mastery
A broader measurement system with testing plans and worked examples.
Explore the report ↗The LifeMeter newsletter
A little more perspective in your inbox.
Stories, useful tools and a closer look at the decisions that matter.
Sign up →